Contrast-enhanced sonographic appearances of two primary hepatic epithelioid angiomyolipomas.
Victor Wern ChaiAdrian FoxLynn ChongEloise HouseTom SutherlandPublished in: Journal of clinical ultrasound : JCU (2020)
Epithelioid hepatic angiomyolipoma (Epi-HAML) is a rare hepatic tumor frequently misdiagnosed as hepatocellular carcinoma (HCC). Unlike conventional angiomyolipoma (AML), Epi-HAML contains minimal amount of adipose tissue, which is a radiological distinguishing feature between AML and HCC. Two patients were referred for management of incidentally found hepatic lesions confirmed to be Epi-HAML on post-resection tissue analysis. CT and MRI findings were suggestive of HCC. Contrast-enhanced ultrasound demonstrated intratumoral shunting, a feeding artery, and early draining hepatic vein. These findings should alert radiologists to the possibility of Epi-HAML. Furthermore, these features may be better assessed by contrast-enhanced ultrasound due to its superior dynamic temporal resolution.
Keyphrases
- contrast enhanced
- contrast enhanced ultrasound
- magnetic resonance imaging
- adipose tissue
- computed tomography
- diffusion weighted
- magnetic resonance
- end stage renal disease
- diffusion weighted imaging
- newly diagnosed
- machine learning
- metabolic syndrome
- ejection fraction
- artificial intelligence
- prognostic factors
- dual energy
- deep learning
- high fat diet
- acute lymphoblastic leukemia
- positron emission tomography
- electronic health record